Statistics on Biotechnology Use  
Results by sector of operation
Sector Companies. Results in biotechnology for main variables and branches of activity 
Unidades: specified in variables

;Total Companies;Services;Industry and Construction;Agriculture;
No. of companies carrying out R&D in Biotechnology;1.133;740;313;80;
%Companies according to biotechnology used: Genetic code;32;39;16;28;
%Companies according to biotechnology used: Functional units;41;44;37;27;
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;27;33;13;27;
%Companies according to biotechnology used: Bioprocesses;48;39;73;37;
%Companies according to biotechnology used: Sub-cellular organisms;8;11;4;1;
%Companies according to biotechnology used: Bio-computing;21;29;7;8;
%Companies according to biotechnology used: Nanobiotechnology;14;18;9;2;
%Companies according to biotechnology used: Other;13;13;11;22;
Companies in which biotechnology activities are: Main and/or exclusive;564;485;70;8;
Companies in which biotechnology activities are: A secondary line of business;212;129;68;15;
Companies in which biotechnology activities are: A tool necessary for production;358;126;174;57;
%Company by field(s) of ultimate application of biotechnology use: Human Health;50;64;28;2;
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;19;19;14;35;
%Company by field(s) of ultimate application of biotechnology use: Food products;29;22;48;28;
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;21;19;18;54;
%Company by field(s) of ultimate application of biotechnology use: Environment;13;13;13;7;
%Company by field(s) of ultimate application of biotechnology use: Industry;13;15;14;1;
Personnel in R&D in biotechnology (no. of persons);10.706;7.082;2.911;713;
Personnel in R&D in biotechnology (no. of persons): Researchers;6.227;4.618;1.376;234;
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;4.479;2.464;1.536;479;
Personnel in R&D in biotechnology (no. of persons): women;5.795;4.017;1.487;291;
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;3.269;2.462;708;99;
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;2.527;1.555;780;192;
Personnel in R&D in biotechnology (FTE);7.716,4;5.271,6;1.994,1;450,7;
Personnel in R&D in biotechnology (FTE): Researchers;4.603,1;3.428,2;1.011,8;163,1;
Personnel in R&D in biotechnology (FTE): Technicians and assistants;3.113,3;1.843,4;982,3;287,6;
Personnel in R&D in biotechnology (FTE): women;4.292,9;2.988,8;1.092,6;211,6;
Personnel in R&D in biotechnology (FTE): (women) Researchers;2.446,4;1.824,2;546,4;75,8;
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;1.846,5;1.164,5;546,2;135,8;
Internal expenditure on R&D (thousands of euros);616.053;419.246;169.526;27.280;
1) By nature of the expense: Current expenses;574.245;386.169;162.807;25.269;
1.1) Remuneration to researchers;221.741;154.058;59.929;7.754;
1.2) Remuneration to technicians and assistants;102.464;54.152;40.900;7.411;
1.3) Other current expenses;250.041;177.959;61.978;10.103;
2) By nature of the expense: Capital expenses;41.808;33.077;6.719;2.012;
2.1) Land and buildings;5.359;3.804;1.179;376;
2.2) Equipment and instruments;29.489;22.799;5.142;1.548;
2.3) Acquisition of specific R&D software;2.306;2.155;150;0;
2.4) Otros productos de propiedad intelectual específicos para I+D;4.654;4.320;247;87;
1) By origin of the funds: National funds;511.960;353.937;132.650;25.373;
1.1) Own funds;382.335;236.135;122.657;23.543;
1.2) From companies;45.024;42.403;2.620;.;
1.3) Public Administration funds;72.387;63.184;7.373;1.830;
1.4) From Universities;363;363;.;.;
1.5) From non profit private institutions;11.851;11.851;.;.;
1) By origin of the funds: Foreign funds;104.093;65.309;36.877;1.907;
2.1) From EU programmes;21.825;20.023;1.726;77;
2.2) Other foreign funds;82.269;45.287;35.151;1.831;
Purchase of R&D services in biotechnology (thousands of euros);144.342;80.058;62.756;1.527;
Purchase of R&D services in biotechnology (thousands of euros): In Spain;70.458;29.338;40.495;625;
Purchase of R&D services in biotechnology (thousands of euros): Abroad;73.885;50.721;22.261;902;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;48;57;31;34;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;13;13;12;19;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;15;16;12;20;
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;12;13;12;7;
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;16;18;11;9;
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels;16;19;11;7;
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;16;17;12;12;
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;36;39;33;21;
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;49;54;38;38;
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;18;19;15;18;
% Companies that have requested biotechnology patents in Biotechnology;16;20;9;5;
Number of patents requested;633;497;87;49;
% Companies with income of an international origin related to biotechnological activities;24;26,6;22,3;6,7;
% Turnover representing income of an international origin related to biotechnological activities;1,4;4,2;1,2;0,7;
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU;57,3;35,2;64,8;44,6;
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries;42,7;64,8;35,2;55,4;
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services;82,3;92;78,8;97;
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;16,5;4,5;20,7;3;
% Income of an international origin related with activities according to the classification: Operating source abroad;1;3,2;0,3;.;
% Income of an international origin related with activities according to the classification: Other;0,3;0,4;0,3;.;
Notas:

.
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute